Though Medicare is launching the GLP-1 Bridge program, offering enrollees temporary discounted access to GLP-1 medications ...

The Editors highlight three aspects of OMB’s recently proposed rule changes as particularly striking: that decisions on research funding would be made by political appointees, that funding could ...

Trainees’ paths to safe, independent practice are variable. Artificial intelligence could help accelerate implementation of competency-based medical education to support individualized development.

Explore this issue of The New England Journal of Medicine (Vol. 392 No. 21).

In 832 patients with rare genetic disease, a conclusive diagnosis was made for 160 patients (19.2%) with long-read genome sequencing and for 137 patients (16.5%) with standard-of-care testing.

We need to consider the ethical challenges inherent in implementing machine learning in health care if its benefits are to be realized. Some of these challenges are straightforward, whereas others ...

To the Editor: In the phase 3 GRADUATE trials of gantenerumab for early Alzheimer’s disease reported by Bateman et al. (Nov. 16 issue), 1 participants receiving gantenerumab had a greater decrease in ...

Hereditary angioedema is a rare and potentially life-threatening genetic condition characterized by recurrent and debilitating swelling attacks. Lonvoguran ziclumeran (lonvo-z) — an investigational, ...

When patients who have become homeless show a physician photos of themselves in better times, they are, in part, asking to be treated fairly, like they are people who might still turn their lives ...

We randomly assigned patients with type 2 diabetes and chronic kidney disease (defined by an estimated glomerular filtration rate [eGFR] of 50 to 75 ml per minute per 1.73 m 2 of body-surface area and ...

A 47-year-old man with heart failure with a reduced ejection fraction and an ICD for the primary prevention of sudden cardiac death presented with an unheralded syncopal event, which had been captured ...

Dr. Elias Zerhouni, director of the National Institutes of Health, discusses translational and clinical research and presents a new plan to provide additional financial support for this important a ...